首页|期刊导航|Oncology Research|MRPL18 Promotes Breast Cancer Progression:Connecting Mitochondrial Ribosomal Protein to Immune Response

MRPL18 Promotes Breast Cancer Progression:Connecting Mitochondrial Ribosomal Protein to Immune Response

Hailong Li Wen Ouyang Yiyin Long Yun Peng Ziyi Liu Qi Zhou Rong Xu Wei Du

Oncology Research2025，Vol.33Issue(9)：P.2549-2571,23.

Oncology Research2025，Vol.33Issue(9)：P.2549-2571,23.DOI:10.32604/or.2025.065050

MRPL18 Promotes Breast Cancer Progression:Connecting Mitochondrial Ribosomal Protein to Immune Response

Hailong Li ¹Wen Ouyang ²Yiyin Long ¹Yun Peng ¹Ziyi Liu ¹Qi Zhou ¹Rong Xu ¹Wei Du¹

作者信息

1. Department of Pathology,Changde Hospital,Xiangya School of Medicine,Central South University(The First People’s Hospital of Changde City),Changde,415000,China
2. Medical Department,Changde Hospital,Xiangya School of Medicine,Central South University(The First People’s Hospital of Changde City),Changde,415000,China
折叠

摘要

关键词

Breast cancer/mitochondrial ribosomal protein L18(MRPL18)/prognostic biomarker/therapeutic target/immune infiltration

分类

医药卫生

引用本文复制引用

Hailong Li,Wen Ouyang,Yiyin Long,Yun Peng,Ziyi Liu,Qi Zhou,Rong Xu,Wei Du..MRPL18 Promotes Breast Cancer Progression:Connecting Mitochondrial Ribosomal Protein to Immune Response[J].Oncology Research,2025,33(9):P.2549-2571,23.

基金项目

supported by grants from the Key Project of Scientific Research Plan of Hunan Provincial Health Commission(C202301047982,Wei Du) （C202301047982,Wei Du）

Changde City Science and Technology Innovation Guidance Plan Project(2022ZD39,Wei Du) （2022ZD39,Wei Du）

the Wings Scientific and Technological Foundation of The First People’s Hospital of Changde City(2022ZZ05,Wei Du,2024ZC02,Rong Xu,Z2025ZC04,Hailong Li) （2022ZZ05,Wei Du,2024ZC02,Rong Xu,Z2025ZC04,Hailong Li）

The Science and Technology Innovation Program of Changde City(2024ZD248,Rong Xu,2024ZD200,Yun Peng). （2024ZD248,Rong Xu,2024ZD200,Yun Peng）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航